resveratrol has been researched along with Epilepsy Progressive Myoclonic 2 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campos, Á; Heredia, M; Mollá, B; Sanz, P | 1 |
1 other study(ies) available for resveratrol and Epilepsy Progressive Myoclonic 2
| Article | Year |
|---|---|
Pharmacological Modulation of Glutamatergic and Neuroinflammatory Pathways in a Lafora Disease Mouse Model.
Topics: Adolescent; Animals; Disease Models, Animal; Dual-Specificity Phosphatases; Humans; Lafora Disease; Memantine; Mice; Mice, Knockout; Minocycline; Myoclonic Epilepsies, Progressive; Protein Tyrosine Phosphatases, Non-Receptor; Resveratrol; Ubiquitin-Protein Ligases | 2022 |